These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15521475

  • 1. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M, Cambou JP, Ferrières J, Grenier O, Herrmann MA, Cantet C, Leizorovicz A.
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
    [Abstract] [Full Text] [Related]

  • 2. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP, Ferrieres J, Grenier O, Boka G, Cantet C, Leizorovicz A.
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [Abstract] [Full Text] [Related]

  • 3. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S.
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Nov; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 6. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators.
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [Abstract] [Full Text] [Related]

  • 7. Acute treatment of myocardial infarction in Canada 1999-2002.
    Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2005 Feb; 21(2):145-52. PubMed ID: 15729413
    [Abstract] [Full Text] [Related]

  • 8. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 12. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 13. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D, Pop D, Sitar-Tăut A, Cebanu M, Zdrenghea V.
    Rom J Intern Med; 2009 Apr; 47(1):41-5. PubMed ID: 19886068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A, Andrikopoulos G, Lekakis J, Kalantzi K, Kitsiou A, Toli K, Floros D, Gaita D, Karalis I, Dragomanovits S, Kalogeropoulos P, Synetos A, Koutsogiannis N, Stougiannos P, Antonakoudis C, Goudevenos J, HELIOS group.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [Abstract] [Full Text] [Related]

  • 16. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
    Philippe F, Cambou JP, Danchin N, Thomas D.
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
    [Abstract] [Full Text] [Related]

  • 17. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
    Cambou JP, Simon T, Mulak G, Bataille V, Danchin N.
    Arch Mal Coeur Vaiss; 2007 Dec; 100(6-7):524-34. PubMed ID: 17893635
    [Abstract] [Full Text] [Related]

  • 18. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA, GRACE Investigators.
    Int J Cardiol; 2007 Jun 25; 119(1):65-72. PubMed ID: 17045681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.